Abstract:Mutation of the APC gene occurs in a high percentage of colorectal tumors and is a central event driving tumor initiation in the large intestine. The APC protein performs multiple tumor suppressor functions including negative regulation of the canonical WNT signaling pathway by both cytoplasmic and nuclear mechanisms. Published reports that APC interacts with β-catenin in the chromatin fraction to repress WNT-activated targets have raised the possibility that chromatin-associated APC participates more broadly in mechanisms of transcriptional control. This screening study has used chromatin immunoprecipitation and next-generation sequencing to identify APC-associated genomic regions in colon cancer cell lines. Initial target selection was performed by comparison and statistical analysis of 3,985 genomic regions associated with the APC protein to whole transcriptome sequencing data from APC-deficient and APC-wild-type colon cancer cells, and two types of murine colon adenomas characterized by activated Wnt signaling. 289 transcripts altered in expression following APC loss in human cells were linked to APC-associated genomic regions. High-confidence targets additionally validated in mouse adenomas included 16 increased and 9 decreased in expression following APC loss, indicating that chromatin-associated APC may antagonize canonical WNT signaling at both WNT-activated and WNT-repressed targets. Motif analysis and comparison to ChIP-seq datasets for other transcription factors identified a prevalence of binding sites for the TCF7L2 and AP-1 transcription factors in APC-associated genomic regions. Our results indicate that canonical WNT signaling can collaborate with or antagonize the AP-1 transcription factor to fine-tune the expression of shared target genes in the colorectal epithelium. Future therapeutic strategies for APC-deficient colorectal cancers might be expanded to include agents targeting the AP-1 pathway.

APC controls Wnt-induced β-catenin destruction complex recruitment in human colonocytes

APC Mutations Disrupt Β-Catenin Destruction Complex Condensates Organized by Axin Phase Separation

Activation of β-Catenin-Tcf Signaling in Colon Cancer by Mutations in β-Catenin or APC

Transcriptional Regulation of Wnt/β-Catenin Pathway in Colorectal Cancer

Distinct CRC-associated APC mutations dictate response to Tankyrase inhibition.

Chromatin-associated APC Regulates Gene Expression in Collaboration with Canonical WNT Signaling and AP-1.

APC regulation of ESRP1 and p120-catenin isoforms in colorectal cancer cells

Wnt signaling and colon carcinogenesis: Beyond APC

The APC tumor suppressor counteracts beta-catenin activation and H3K4 methylation at Wnt target genes

Wnt/β-catenin Singal Transduction Pathway and Colorectal Cancer

Mechanism of APC truncation involved in colorectal cancer tumorigenesis (Review)

β-catenin mediates growth defects induced by centrosome loss in a subset of APC mutant colorectal cancer independently of p53

Intracellular complement C5a/C5aR1 stabilizes β-catenin to promote colorectal tumorigenesis

Crystal structure of a β-catenin/Axin complex suggests a mechanism for the β-catenin destruction complex

Adenomatous polyposis coli in cancer and therapeutic implications

Molecular regulation and pharmacological targeting of the β-catenin destruction complex

Role of Oncogenic K-Ras in Cancer Stem Cell Activation by Aberrant Wnt/β-Catenin Signaling

To β or not to β: Lack of correlation between APC mutation and β-catenin nuclear localization in colorectal cancer

Targeting the Wnt signaling pathway in colorectal cancer

Nuclear adenomatous polyposis coli suppresses colitis-associated tumorigenesis in mice

Interaction between Wnt/β-catenin and RAS-ERK pathways and an anti-cancer strategy via degradations of β-catenin and RAS by targeting the Wnt/β-catenin pathway